Description

ATEHEAL 50 MG

Indications

ATEHEAL 50 MG is primarily indicated for the treatment of various inflammatory conditions, including rheumatoid arthritis, osteoarthritis, and other musculoskeletal disorders. It is also used in the management of pain associated with acute injuries and chronic conditions. The medication may be prescribed to alleviate symptoms such as swelling, pain, and stiffness, improving the overall quality of life for patients suffering from these conditions.

Mechanism of Action

ATEHEAL 50 MG works by inhibiting the production of certain chemicals in the body that are responsible for inflammation and pain. Specifically, it targets the cyclooxygenase (COX) enzymes, which play a crucial role in the conversion of arachidonic acid to prostaglandins. By reducing the levels of these inflammatory mediators, ATEHEAL effectively decreases pain and inflammation, leading to symptom relief in patients.

Pharmacological Properties

ATEHEAL 50 MG is classified as a non-steroidal anti-inflammatory drug (NSAID). It possesses analgesic, anti-inflammatory, and antipyretic properties. The pharmacokinetics of ATEHEAL indicate that it is rapidly absorbed after oral administration, with peak plasma concentrations typically reached within 1-2 hours. The drug is metabolized in the liver and excreted primarily through the kidneys. Its half-life allows for once or twice daily dosing, making it convenient for patient adherence.

Contraindications

ATEHEAL 50 MG is contraindicated in individuals with a known hypersensitivity to the active ingredient or any of the excipients in the formulation. It should not be used in patients with a history of gastrointestinal bleeding, peptic ulcer disease, or severe renal impairment. Additionally, ATEHEAL is contraindicated during the third trimester of pregnancy due to the risk of fetal harm.

Side Effects

Common side effects associated with ATEHEAL 50 MG may include gastrointestinal disturbances such as nausea, vomiting, dyspepsia, and diarrhea. Other potential side effects can include dizziness, headache, and rash. Serious adverse effects, although rare, may involve cardiovascular events, liver dysfunction, or renal impairment. Patients should be advised to report any unusual symptoms or side effects to their healthcare provider promptly.

Dosage and Administration

The recommended dosage of ATEHEAL 50 MG varies depending on the specific condition being treated and the patient’s response to therapy. For adults, the usual starting dose is one tablet taken orally once or twice daily, preferably with food to minimize gastrointestinal irritation. The dosage may be adjusted based on the severity of symptoms and the patient’s overall health status. It is essential for patients to follow their healthcare provider’s instructions regarding dosage and duration of treatment.

Interactions

ATEHEAL 50 MG may interact with other medications, which can affect its efficacy and safety. Notable interactions include anticoagulants, as the combination may increase the risk of bleeding. Other NSAIDs and corticosteroids should be avoided concurrently, as they can exacerbate gastrointestinal side effects. Additionally, caution is advised when ATEHEAL is used alongside antihypertensive agents, as it may reduce their effectiveness. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Precautions

Before starting treatment with ATEHEAL 50 MG, patients should be assessed for any pre-existing medical conditions, particularly those affecting the gastrointestinal, renal, or cardiovascular systems. It is essential to use this medication with caution in elderly patients, as they may be more susceptible to adverse effects. Regular monitoring of renal function and liver enzymes is recommended during prolonged therapy. Patients should also be advised to avoid alcohol consumption while taking ATEHEAL, as it may increase the risk of gastrointestinal complications.

Clinical Studies

Clinical studies evaluating the efficacy and safety of ATEHEAL 50 MG have demonstrated its effectiveness in reducing pain and inflammation associated with various conditions. In a randomized controlled trial involving patients with osteoarthritis, ATEHEAL significantly improved pain scores compared to placebo, with a favorable safety profile. Another study indicated that ATEHEAL was effective in managing rheumatoid arthritis symptoms, leading to improved physical function and quality of life. These findings support the use of ATEHEAL as a viable option in the management of inflammatory and painful conditions.

Conclusion

ATEHEAL 50 MG is a valuable therapeutic option for patients suffering from inflammatory conditions and pain. Its mechanism of action, pharmacological properties, and clinical efficacy make it a suitable choice for managing symptoms associated with arthritis and other musculoskeletal disorders. However, it is crucial for patients to be aware of potential side effects and drug interactions. Healthcare providers should ensure that patients are adequately informed and monitored throughout their treatment to maximize benefits and minimize risks.